These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3896215

  • 1. Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents.
    Colman PG, Harrison LC, Tait BD.
    Aust N Z J Med; 1985 Apr; 15(2):209-12. PubMed ID: 3896215
    [Abstract] [Full Text] [Related]

  • 2. Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
    Zavala AV, Fabiano de Bruno LE, Cardoso AI, Mota AH, Capucchio M, Poskus E, Fainboim L, Basabe JC.
    Diabetologia; 1992 Dec; 35(12):1159-64. PubMed ID: 1478368
    [Abstract] [Full Text] [Related]

  • 3. [Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs].
    Maiz A, Manrique M, Arteaga A, Acosta AM, Andrade L.
    Rev Med Chil; 1995 Oct; 123(10):1199-203. PubMed ID: 8733310
    [Abstract] [Full Text] [Related]

  • 4. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L, Miettinen A, Groop PH, Meri S, Koskimies S, Bottazzo GF.
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [Abstract] [Full Text] [Related]

  • 5. Gestational diabetes mellitus. Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring.
    Freinkel N, Metzger BE, Phelps RL, Dooley SL, Ogata ES, Radvany RM, Belton A.
    Diabetes; 1985 Jun; 34 Suppl 2():1-7. PubMed ID: 3888733
    [Abstract] [Full Text] [Related]

  • 6. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H, Zörcher B, Greulich B, Gries FA, Henrichs HR, Betrams J, Kolb H.
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [Abstract] [Full Text] [Related]

  • 7. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V.
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [Abstract] [Full Text] [Related]

  • 8. Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.
    Groop LC, Pelkonen R, Koskimies S, Bottazzo GF, Doniach D.
    Diabetes Care; 1986 Jun; 9(2):129-33. PubMed ID: 3516607
    [Abstract] [Full Text] [Related]

  • 9. [Diabetes mellitus in the elderly: a study on its clinical presentation, C-peptide reserve, and immunogenetic markers of insulin dependence].
    Seclén Santisteban S, Alvarez Huamán RI, Chantres Antoranz MT, Serrano Ríos M.
    Rev Clin Esp; 1993 Mar; 192(4):162-8. PubMed ID: 8480059
    [Abstract] [Full Text] [Related]

  • 10. Insulin treatment improved glucose-induced insulin release in elderly non-insulin-dependent diabetes mellitus, secondary failure to oral hypoglycemic agents.
    Jap TS, Kwok CF, Won JG, Ho LT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):320-4. PubMed ID: 1649673
    [Abstract] [Full Text] [Related]

  • 11. Gestational diabetes mellitus: a syndrome with phenotypic and genotypic heterogeneity.
    Freinkel N, Metzger BE, Phelps RL, Simpson JL, Martin AO, Radvany R, Ober C, Dooley SL, Depp RO, Belton A.
    Horm Metab Res; 1986 Jul; 18(7):427-30. PubMed ID: 3527923
    [Abstract] [Full Text] [Related]

  • 12. Secondary failure to oral hypoglycaemic agents in non-obese patients with non-insulin-dependent diabetes is related to reduced insulin release.
    Pontiroli AE, Calderara A, Maffi P, Bonisolli L, Carenini A, Piatti PM, Monti LD, Gallus G, Pozza G, Illeni MT.
    Diabete Metab; 1989 Jul; 15(2):79-84. PubMed ID: 2661281
    [Abstract] [Full Text] [Related]

  • 13. Serum C-peptide concentrations and their value in evaluating the usefulness of insulin therapy in elderly diabetics.
    Kyllästinen M, Elfving S.
    Gerontology; 1986 Jul; 32(6):317-26. PubMed ID: 3556328
    [Abstract] [Full Text] [Related]

  • 14. [HLA-antigens and islet cell antibodies in type-1 diabetics of various age groups and their first-degree relatives].
    Spinas GA, Keller U, Neri TM, Matter L, Staffelbach O, Berger W.
    Schweiz Med Wochenschr; 1985 Jan 12; 115(2):48-54. PubMed ID: 3881821
    [Abstract] [Full Text] [Related]

  • 15. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
    Lorini R, Alibrandi A, Vitali L, Klersy C, Martinetti M, Betterle C, d'Annunzio G, Bonifacio E, Pediatric Italian Study Group of Prediabetes.
    Diabetes Care; 2001 Jul 12; 24(7):1210-6. PubMed ID: 11423504
    [Abstract] [Full Text] [Related]

  • 16. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
    Wolffenbuttel BH, Menheere PP, Nijst L, Rondas-Colbers GJ, Sels JP, Nieuwenhuijzen Kruseman AC.
    Neth J Med; 1992 Jun 12; 40(5-6):277-82. PubMed ID: 1436266
    [Abstract] [Full Text] [Related]

  • 17. Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects.
    Snorgaard O, Hasselstrøm K, Lumholtz IB, Thorsteinsson B, Siersbaek-Nielsen K.
    Acta Endocrinol (Copenh); 1988 Jan 12; 117(1):109-15. PubMed ID: 3289292
    [Abstract] [Full Text] [Related]

  • 18. Is type 2 diabetes a different disease in obese and nonobese patients?
    Prando R, Cheli V, Melga P, Giusti R, Ciuchi E, Odetti P.
    Diabetes Care; 1998 Oct 12; 21(10):1680-5. PubMed ID: 9773730
    [Abstract] [Full Text] [Related]

  • 19. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A.
    J Clin Endocrinol Metab; 1996 Apr 12; 81(4):1488-94. PubMed ID: 8636356
    [Abstract] [Full Text] [Related]

  • 20. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT, Goulas S, Wollen N, McIntyre N.
    J Hepatol; 1998 Feb 12; 28(2):280-91. PubMed ID: 9514541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.